Hinton JP - Search Results

1

A sensitive high-performance liquid chromatographic assay for the cholecystokinin-B antagonist, CI-988, in human and monkey plasma.

Hinton JP, Jennings K, Johnson EL, Wright DS. Hinton JP, et al. Biomed Chromatogr. 1995 Mar-Apr;9(2):94-7. doi: 10.1002/bmc.1130090208. Biomed Chromatogr. 1995. PMID: 7795393

2

Three complementary liquid chromatographic methods for determination of the peptoid cholecystokinin-B antagonist, CI-988, in rat plasma.

Hinton JP, Pablo JC, Bjorge SM, Hoffman K, Jennings K, Wright DS. Hinton JP, et al. J Pharm Biomed Anal. 1996 May;14(7):815-24. doi: 10.1016/0731-7085(95)01686-4. J Pharm Biomed Anal. 1996. PMID: 8809706

3

Second generation "peptoid" CCK-B receptor antagonists: identification and development of N-(adamantyloxycarbonyl)-alpha-methyl-(R)-tryptophan derivative (CI-1015) with an improved pharmacokinetic profile.

Trivedi BK, Padia JK, Holmes A, Rose S, Wright DS, Hinton JP, Pritchard MC, Eden JM, Kneen C, Webdale L, Suman-Chauhan N, Boden P, Singh L, Field MJ, Hill D. Trivedi BK, et al. Among authors: hinton jp. J Med Chem. 1998 Jan 1;41(1):38-45. doi: 10.1021/jm970065l. J Med Chem. 1998. PMID: 9438020

4

CI-1015. An orally active CCK-B receptor antagonist with an improved pharmacokinetic profile.

Trivedi BK, Hinton JP. Trivedi BK, et al. Among authors: hinton jp. Pharm Biotechnol. 1998;11:481-505. Pharm Biotechnol. 1998. PMID: 9760693 Review. No abstract available.

5

Novel nonpeptide CCK-B antagonists: design and development of quinazolinone derivatives as potent, selective, and orally active CCK-B antagonists.

Padia JK, Field M, Hinton J, Meecham K, Pablo J, Pinnock R, Roth BD, Singh L, Suman-Chauhan N, Trivedi BK, Webdale L. Padia JK, et al. J Med Chem. 1998 Mar 26;41(7):1042-9. doi: 10.1021/jm970373j. J Med Chem. 1998. PMID: 9544204

6

Effect of CI-988 on cholecystokinin tetrapeptide-induced panic symptoms in healthy volunteers.

Bradwejn J, Koszycki D, Paradis M, Reece P, Hinton J, Sedman A. Bradwejn J, et al. Biol Psychiatry. 1995 Dec 1;38(11):742-6. doi: 10.1016/0006-3223(95)00081-X. Biol Psychiatry. 1995. PMID: 8580227 Clinical Trial.

7

Unbound plasma concentrations may predict neuroprotective brain concentrations: a brain microdialysis and pharmacokinetic study of enadoline in rats.

Hinton JP, Hudson G. Hinton JP, et al. Acta Neurochir Suppl. 1999;75:7-9. doi: 10.1007/978-3-7091-6415-0_2. Acta Neurochir Suppl. 1999. PMID: 10635368

8

Transcriptional Profiling of Malignant Melanoma Reveals Novel and Potentially Targetable Gene Fusions.

Darabi S, Elliott A, Braxton DR, Zeng J, Hodges K, Poorman K, Swensen J, Shanthappa BU, Hinton JP, Gibney GT, Moser J, Phung T, Atkins MB, In GK, Korn WM, Eisenberg BL, Demeure MJ. Darabi S, et al. Among authors: hinton jp. Cancers (Basel). 2022 Mar 15;14(6):1505. doi: 10.3390/cancers14061505. Cancers (Basel). 2022. PMID: 35326655 Free PMC article.

9

A Method to Reuse Archived H&E Stained Histology Slides for a Multiplex Protein Biomarker Analysis.

Hinton JP, Dvorak K, Roberts E, French WJ, Grubbs JC, Cress AE, Tiwari HA, Nagle RB. Hinton JP, et al. Methods Protoc. 2019 Nov 15;2(4):86. doi: 10.3390/mps2040086. Methods Protoc. 2019. PMID: 31731599 Free PMC article.

10

Gene Editing of α6 Integrin Inhibits Muscle Invasive Networks and Increases Cell-Cell Biophysical Properties in Prostate Cancer.

Rubenstein CS, Gard JMC, Wang M, McGrath JE, Ingabire N, Hinton JP, Marr KD, Simpson SJ, Nagle RB, Miranti CK, Warfel NA, Garcia JGN, Arif-Tiwari H, Cress AE. Rubenstein CS, et al. Among authors: hinton jp. Cancer Res. 2019 Sep 15;79(18):4703-4714. doi: 10.1158/0008-5472.CAN-19-0868. Epub 2019 Jul 23. Cancer Res. 2019. PMID: 31337652 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

20 results

Search Page